Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference

The new mini-textbook by Kamps & Hoffmann
PDF, 110 pages


  Lung Cancer

  Free Subscription


23.03.2020

1 Ann Oncol
1 Ann Thorac Surg
1 Arch Bronconeumol
1 BMC Cancer
1 Cancer Lett
3 Clin Lung Cancer
1 Eur J Cancer
1 Int J Radiat Oncol Biol Phys
1 J Surg Oncol
3 J Thorac Oncol
2 JAMA Oncol
1 Lancet Oncol
1 Lung Cancer (Auckl)
1 Mol Carcinog
1 Oncol Rep
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Oncol

  1. LAMBERTI G, Spurr LF, Li Y, Ricciuti B, et al
    Clinicopathological and genomic correlates of Programmed Cell Death Ligand 1 (PD-L1) expression in nonsquamous non-small cell lung cancer.
    Ann Oncol. 2020 Mar 11. pii: S0923-7534(20)36078.
    PubMed     Text format     Abstract available


    Ann Thorac Surg

  2. ELY S, Jiang SF, Patel AR, Ashiku SK, et al
    Regionalization of Lung Cancer SurgeryImproves Outcomes in an Integrated Healthcare System.
    Ann Thorac Surg. 2020 Mar 14. pii: S0003-4975(20)30375.
    PubMed     Text format     Abstract available


    Arch Bronconeumol

  3. MOISES J, Navarro A, Castellano JJ, Vinolas N, et al
    Long Non-Coding RNA NANCI/NKX2-1 Duplex Impacts Prognosis in Stage I Non-Small-Cell Lung Cancer.
    Arch Bronconeumol. 2020 Mar 13. pii: S0300-2896(20)30037.
    PubMed     Text format     Abstract available


    BMC Cancer

  4. NAWROCKI S, Sugajska A
    Study protocol: watchful observation of patients with limited small cell lung cancer instead of the PCI-prospective, multi-center one-arm study.
    BMC Cancer. 2020;20:231.
    PubMed     Text format     Abstract available


    Cancer Lett

  5. LI Y, Liang R, Sun M, Li Z, et al
    AMPK-Dependent Phosphorylation of HDAC8 Triggers PGM1 Expression to Promote Lung Cancer Cell Survival under Glucose Starvation.
    Cancer Lett. 2020 Mar 11. pii: S0304-3835(20)30126.
    PubMed     Text format     Abstract available


    Clin Lung Cancer

  6. GERBER DE, Hamann HA, Chavez C, Dorsey O, et al
    Tracking the Nonenrolled: Lung Cancer Screening Patterns Among Individuals not Accrued to a Clinical Trial.
    Clin Lung Cancer. 2020 Feb 26. pii: S1525-7304(20)30035.
    PubMed     Text format     Abstract available

  7. ARNOLD SM, Chansky K, Baggstrom MQ, Thompson MA, et al
    Phase II Trial of Carfilzomib Plus Irinotecan in Patients With Small-cell Lung Cancer Who Have Progressed on Prior Platinum-based Chemotherapy.
    Clin Lung Cancer. 2020 Jan 27. pii: S1525-7304(20)30006.
    PubMed     Text format     Abstract available

  8. BAEK J, Owen DH, Merritt RE, Shilo K, et al
    Minimally Invasive Lobectomy for Residual Primary Tumors of Advanced Non-Small-Cell Lung Cancer After Treatment With Immune Checkpoint Inhibitors: Case Series and Clinical Considerations.
    Clin Lung Cancer. 2020 Feb 25. pii: S1525-7304(20)30041.
    PubMed     Text format    


    Eur J Cancer

  9. BOUDOU-ROUQUETTE P, Grignano E, Arrondeau J, Burroni B, et al
    Diffuse large B-cell lymphoma after nivolumab treatment for lung cancer: A case report and a World Health Organization pharmacovigilance database review.
    Eur J Cancer. 2020;130:20-22.
    PubMed     Text format    


    Int J Radiat Oncol Biol Phys

  10. KLEMENT RJ, Sonke JJ, Allgauer M, Andratschke N, et al
    Correlating dose variables with local tumor control in stereotactic body radiotherapy for early stage non-small cell lung cancer: A modelling study on 1500 individual treatments.
    Int J Radiat Oncol Biol Phys. 2020 Mar 15. pii: S0360-3016(20)30897.
    PubMed     Text format     Abstract available


    J Surg Oncol

  11. SHI S, Xie H, Yin W, Zhang Y, et al
    The prognostic significance of the 8th edition AJCC TNM staging system for non-small-cell lung cancer is not applicable to lung cancer as a second primary malignancy.
    J Surg Oncol. 2020 Mar 14. doi: 10.1002/jso.25903.
    PubMed     Text format     Abstract available


    J Thorac Oncol

  12. MEZQUITA L, Jove M, Nadal E, Kfoury M, et al
    Brief report: High prevalence of somatic oncogenic driver alterations in non-small cell lung cancer patients with Li-Fraumeni Syndrome.
    J Thorac Oncol. 2020 Mar 13. pii: S1556-0864(20)30197.
    PubMed     Text format     Abstract available

  13. PAZ-ARES L, Kim TM, Vicente D, Felip E, et al
    Bintrafusp alfa, a bifunctional fusion protein targeting TGF-beta and PD-L1, in second-line treatment of patients with non-small cell lung cancer: results from an expansion cohort of a phase 1 trial.
    J Thorac Oncol. 2020 Mar 12. pii: S1556-0864(20)30195.
    PubMed     Text format     Abstract available

  14. LURIENNE L, Cervesi J, Duhalde L, de Gunzburg J, et al
    Non-small-cell lung cancer immunotherapy efficacy and antibiotic use: a systematic review and meta-analysis.
    J Thorac Oncol. 2020 Mar 12. pii: S1556-0864(20)30194.
    PubMed     Text format     Abstract available


    JAMA Oncol

  15. YANG JJ, Yu D, Shu XO
    Association of Dietary Fiber and Yogurt Consumption With Lung Cancer Risk-Reply.
    JAMA Oncol. 2020 Mar 19. pii: 2762588. doi: 10.1001/jamaoncol.2020.0270.
    PubMed     Text format    

  16. WU Q, Leung EL
    Association of Dietary Fiber and Yogurt Consumption With Lung Cancer Risk.
    JAMA Oncol. 2020 Mar 19. pii: 2762586. doi: 10.1001/jamaoncol.2020.0261.
    PubMed     Text format    


    Lancet Oncol

  17. NESTLE U, Schimek-Jasch T, Kremp S, Schaefer-Schuler A, et al
    Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial.
    Lancet Oncol. 2020 Mar 12. pii: S1470-2045(20)30013.
    PubMed     Text format     Abstract available


    Lung Cancer (Auckl)

  18. KAUFFMANN-GUERRERO D, Huber RM
    Orphan Drugs in Development for the Treatment of Small-Cell Lung Cancer: Emerging Data on Lurbinectedin.
    Lung Cancer (Auckl). 2020;11:27-31.
    PubMed     Text format     Abstract available


    Mol Carcinog

  19. ZHANG Q, Chen M, Cao L, Ren Y, et al
    Phenethyl isothiocyanate synergistically induces apoptosis with Gefitinib in non-small cell lung cancer cells via endoplasmic reticulum stress-mediated degradation of Mcl-1.
    Mol Carcinog. 2020 Mar 18. doi: 10.1002/mc.23184.
    PubMed     Text format     Abstract available


    Oncol Rep

  20. NENKOV M, Ma Y, Haase D, Zhou Z, et al
    Growth inhibitory role of the p53 activator SCH 529074 in nonsmall cell lung cancer cells expressing mutant p53.
    Oncol Rep. 2020 Mar 17. doi: 10.3892/or.2020.7546.
    PubMed     Text format     Abstract available


    PLoS One

  21. BOBBILI P, Ryan K, DerSarkissian M, Dua A, et al
    Predictors of chemoradiotherapy versus single modality therapy and overall survival among patients with unresectable, stage III non-small cell lung cancer.
    PLoS One. 2020;15:e0230444.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: